Novel Combination Cancer Immunotherapy Summit 2024
Evvnt Promotion / evvnt
Archiv
15.10.2024 - 17.10.2024 Sheraton Mission Valley San Diego Hotel, 1433 Camino del Rio South, 92108 San Diego, California, USA
Time: 9:00 AM - 4:00 PM
Kongressthemen
Welcome to the Novel Combination Cancer Immunotherapy Summit - Supercharging Immunotherapies with Rational Combinations of ICIS, OVs, Adoptive Cells and Beyond
Welcome to the Novel Combination Cancer Immunotherapy Summit - Supercharging Immunotherapies with Rational Combinations of ICIS, OVs, Adoptive Cells and Beyond
Kongressorganizer (PCO)
Hanson Wade Group
Hanson Wade Group
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2511263-2?pid=4832
Speakers: Michael Chisamore, Executive Director, Clinical Research, Merck and Co, Raj Ganesan, Executive Director, Oncology, Amgen , Yuanming Xu, Associate Director, Pfizer, and more
URL:
Brochure: https://go.evvnt.com/2511263-2?pid=4832
Speakers: Michael Chisamore, Executive Director, Clinical Research, Merck and Co, Raj Ganesan, Executive Director, Oncology, Amgen , Yuanming Xu, Associate Director, Pfizer, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2511263-1?pid=4832
Frau Nell Sydenham
Onkologie
Sprache
Englisch
Englisch
Kongressgebühr
USD 1899.00 - USD 3997.00
USD 1899.00 - USD 3997.00
Teilnehmer erwartet
1000 - 1000
1000 - 1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
